Financhill
Sell
30

OSCR Quote, Financials, Valuation and Earnings

Last price:
$13.24
Seasonality move :
6.62%
Day range:
$12.99 - $13.67
52-week range:
$11.20 - $23.80
Dividend yield:
0%
P/E ratio:
51.21x
P/S ratio:
0.31x
P/B ratio:
4.03x
Volume:
6M
Avg. volume:
9.3M
1-year change:
-17.67%
Market cap:
$3.9B
Revenue:
$11.7B
EPS (TTM):
-$1.75

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
OSCR
Oscar Health, Inc.
$3.1B -$0.92 61.86% 31.85% $15.40
CI
The Cigna Group
$69.1B $7.88 1.33% 56.45% $332.62
CNC
Centene Corp.
$48.4B -$1.22 1.68% -14.91% $44.24
ELV
Elevance Health, Inc.
$49.4B $3.09 -0.75% 9.85% $387.85
MOH
Molina Healthcare, Inc.
$10.9B $0.33 -1.34% -48.25% $157.56
UNH
UnitedHealth Group, Inc.
$113.7B $2.11 0.24% 0.32% $364.63
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
OSCR
Oscar Health, Inc.
$13.23 $15.40 $3.9B 51.21x $0.00 0% 0.31x
CI
The Cigna Group
$280.31 $332.62 $73.9B 12.63x $1.51 2.16% 0.35x
CNC
Centene Corp.
$43.24 $44.24 $21.3B 8.66x $0.00 0% 0.11x
ELV
Elevance Health, Inc.
$342.93 $387.85 $75.7B 13.66x $1.71 2% 0.39x
MOH
Molina Healthcare, Inc.
$151.00 $157.56 $7.8B 17.65x $0.00 0% 0.18x
UNH
UnitedHealth Group, Inc.
$290.00 $364.63 $262.7B 21.98x $2.21 3.01% 0.59x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
OSCR
Oscar Health, Inc.
30.55% 3.462 10.05% 0.00x
CI
The Cigna Group
-- -1.212 -- 0.00x
CNC
Centene Corp.
47.65% -0.471 89.3% 0.00x
ELV
Elevance Health, Inc.
42.7% -1.167 42.19% 0.00x
MOH
Molina Healthcare, Inc.
49.7% -1.435 45.08% 0.00x
UNH
UnitedHealth Group, Inc.
45.55% -0.826 26.07% 0.00x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
OSCR
Oscar Health, Inc.
-- -$333.7M -29.38% -40.11% -12.57% $662.8M
CI
The Cigna Group
-- $2.6B 9.38% 15.18% -- $3.1B
CNC
Centene Corp.
-- -$1.2B -15.59% -27.11% -3.1% $224M
ELV
Elevance Health, Inc.
-- $581M 7.59% 13.1% 0.43% -$209M
MOH
Molina Healthcare, Inc.
-- -$162M 5.89% 10.89% -1.88% -$297M
UNH
UnitedHealth Group, Inc.
-- $380M 6.92% 17.57% -0.64% $160M

Oscar Health, Inc. vs. Competitors

  • Which has Higher Returns OSCR or CI?

    The Cigna Group has a net margin of -12.56% compared to Oscar Health, Inc.'s net margin of 8.72%. Oscar Health, Inc.'s return on equity of -40.11% beat The Cigna Group's return on equity of 15.18%.

    Company Gross Margin Earnings Per Share Invested Capital
    OSCR
    Oscar Health, Inc.
    -- -$1.24 $1.4B
    CI
    The Cigna Group
    -- $4.64 $41.7B
  • What do Analysts Say About OSCR or CI?

    Oscar Health, Inc. has a consensus price target of $15.40, signalling upside risk potential of 16.4%. On the other hand The Cigna Group has an analysts' consensus of $332.62 which suggests that it could grow by 18.66%. Given that The Cigna Group has higher upside potential than Oscar Health, Inc., analysts believe The Cigna Group is more attractive than Oscar Health, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    OSCR
    Oscar Health, Inc.
    0 5 2
    CI
    The Cigna Group
    15 4 0
  • Is OSCR or CI More Risky?

    Oscar Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Cigna Group has a beta of 0.271, suggesting its less volatile than the S&P 500 by 72.946%.

  • Which is a Better Dividend Stock OSCR or CI?

    Oscar Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Cigna Group offers a yield of 2.16% to investors and pays a quarterly dividend of $1.51 per share. Oscar Health, Inc. pays -- of its earnings as a dividend. The Cigna Group pays out 27.23% of its earnings as a dividend. The Cigna Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios OSCR or CI?

    Oscar Health, Inc. quarterly revenues are $2.8B, which are smaller than The Cigna Group quarterly revenues of $14.2B. Oscar Health, Inc.'s net income of -$352.4M is lower than The Cigna Group's net income of $1.2B. Notably, Oscar Health, Inc.'s price-to-earnings ratio is 51.21x while The Cigna Group's PE ratio is 12.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health, Inc. is 0.31x versus 0.35x for The Cigna Group. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OSCR
    Oscar Health, Inc.
    0.31x 51.21x $2.8B -$352.4M
    CI
    The Cigna Group
    0.35x 12.63x $14.2B $1.2B
  • Which has Higher Returns OSCR or CNC?

    Centene Corp. has a net margin of -12.56% compared to Oscar Health, Inc.'s net margin of -2.21%. Oscar Health, Inc.'s return on equity of -40.11% beat Centene Corp.'s return on equity of -27.11%.

    Company Gross Margin Earnings Per Share Invested Capital
    OSCR
    Oscar Health, Inc.
    -- -$1.24 $1.4B
    CNC
    Centene Corp.
    -- -$2.24 $38.2B
  • What do Analysts Say About OSCR or CNC?

    Oscar Health, Inc. has a consensus price target of $15.40, signalling upside risk potential of 16.4%. On the other hand Centene Corp. has an analysts' consensus of $44.24 which suggests that it could grow by 2.3%. Given that Oscar Health, Inc. has higher upside potential than Centene Corp., analysts believe Oscar Health, Inc. is more attractive than Centene Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    OSCR
    Oscar Health, Inc.
    0 5 2
    CNC
    Centene Corp.
    3 13 1
  • Is OSCR or CNC More Risky?

    Oscar Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Centene Corp. has a beta of 0.483, suggesting its less volatile than the S&P 500 by 51.703%.

  • Which is a Better Dividend Stock OSCR or CNC?

    Oscar Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Centene Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Oscar Health, Inc. pays -- of its earnings as a dividend. Centene Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OSCR or CNC?

    Oscar Health, Inc. quarterly revenues are $2.8B, which are smaller than Centene Corp. quarterly revenues of $49.7B. Oscar Health, Inc.'s net income of -$352.4M is higher than Centene Corp.'s net income of -$1.1B. Notably, Oscar Health, Inc.'s price-to-earnings ratio is 51.21x while Centene Corp.'s PE ratio is 8.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health, Inc. is 0.31x versus 0.11x for Centene Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OSCR
    Oscar Health, Inc.
    0.31x 51.21x $2.8B -$352.4M
    CNC
    Centene Corp.
    0.11x 8.66x $49.7B -$1.1B
  • Which has Higher Returns OSCR or ELV?

    Elevance Health, Inc. has a net margin of -12.56% compared to Oscar Health, Inc.'s net margin of 1.1%. Oscar Health, Inc.'s return on equity of -40.11% beat Elevance Health, Inc.'s return on equity of 13.1%.

    Company Gross Margin Earnings Per Share Invested Capital
    OSCR
    Oscar Health, Inc.
    -- -$1.24 $1.4B
    ELV
    Elevance Health, Inc.
    -- $2.47 $76.7B
  • What do Analysts Say About OSCR or ELV?

    Oscar Health, Inc. has a consensus price target of $15.40, signalling upside risk potential of 16.4%. On the other hand Elevance Health, Inc. has an analysts' consensus of $387.85 which suggests that it could grow by 13.1%. Given that Oscar Health, Inc. has higher upside potential than Elevance Health, Inc., analysts believe Oscar Health, Inc. is more attractive than Elevance Health, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    OSCR
    Oscar Health, Inc.
    0 5 2
    ELV
    Elevance Health, Inc.
    11 8 0
  • Is OSCR or ELV More Risky?

    Oscar Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Elevance Health, Inc. has a beta of 0.500, suggesting its less volatile than the S&P 500 by 50.02%.

  • Which is a Better Dividend Stock OSCR or ELV?

    Oscar Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Elevance Health, Inc. offers a yield of 2% to investors and pays a quarterly dividend of $1.71 per share. Oscar Health, Inc. pays -- of its earnings as a dividend. Elevance Health, Inc. pays out 27.13% of its earnings as a dividend. Elevance Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios OSCR or ELV?

    Oscar Health, Inc. quarterly revenues are $2.8B, which are smaller than Elevance Health, Inc. quarterly revenues of $49.7B. Oscar Health, Inc.'s net income of -$352.4M is lower than Elevance Health, Inc.'s net income of $546M. Notably, Oscar Health, Inc.'s price-to-earnings ratio is 51.21x while Elevance Health, Inc.'s PE ratio is 13.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health, Inc. is 0.31x versus 0.39x for Elevance Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OSCR
    Oscar Health, Inc.
    0.31x 51.21x $2.8B -$352.4M
    ELV
    Elevance Health, Inc.
    0.39x 13.66x $49.7B $546M
  • Which has Higher Returns OSCR or MOH?

    Molina Healthcare, Inc. has a net margin of -12.56% compared to Oscar Health, Inc.'s net margin of -1.41%. Oscar Health, Inc.'s return on equity of -40.11% beat Molina Healthcare, Inc.'s return on equity of 10.89%.

    Company Gross Margin Earnings Per Share Invested Capital
    OSCR
    Oscar Health, Inc.
    -- -$1.24 $1.4B
    MOH
    Molina Healthcare, Inc.
    -- -$3.14 $8.1B
  • What do Analysts Say About OSCR or MOH?

    Oscar Health, Inc. has a consensus price target of $15.40, signalling upside risk potential of 16.4%. On the other hand Molina Healthcare, Inc. has an analysts' consensus of $157.56 which suggests that it could grow by 4.35%. Given that Oscar Health, Inc. has higher upside potential than Molina Healthcare, Inc., analysts believe Oscar Health, Inc. is more attractive than Molina Healthcare, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    OSCR
    Oscar Health, Inc.
    0 5 2
    MOH
    Molina Healthcare, Inc.
    3 13 0
  • Is OSCR or MOH More Risky?

    Oscar Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Molina Healthcare, Inc. has a beta of 0.495, suggesting its less volatile than the S&P 500 by 50.546%.

  • Which is a Better Dividend Stock OSCR or MOH?

    Oscar Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Molina Healthcare, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Oscar Health, Inc. pays -- of its earnings as a dividend. Molina Healthcare, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OSCR or MOH?

    Oscar Health, Inc. quarterly revenues are $2.8B, which are smaller than Molina Healthcare, Inc. quarterly revenues of $11.4B. Oscar Health, Inc.'s net income of -$352.4M is lower than Molina Healthcare, Inc.'s net income of -$160M. Notably, Oscar Health, Inc.'s price-to-earnings ratio is 51.21x while Molina Healthcare, Inc.'s PE ratio is 17.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health, Inc. is 0.31x versus 0.18x for Molina Healthcare, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OSCR
    Oscar Health, Inc.
    0.31x 51.21x $2.8B -$352.4M
    MOH
    Molina Healthcare, Inc.
    0.18x 17.65x $11.4B -$160M
  • Which has Higher Returns OSCR or UNH?

    UnitedHealth Group, Inc. has a net margin of -12.56% compared to Oscar Health, Inc.'s net margin of 0.19%. Oscar Health, Inc.'s return on equity of -40.11% beat UnitedHealth Group, Inc.'s return on equity of 17.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    OSCR
    Oscar Health, Inc.
    -- -$1.24 $1.4B
    UNH
    UnitedHealth Group, Inc.
    -- $0.01 $185.9B
  • What do Analysts Say About OSCR or UNH?

    Oscar Health, Inc. has a consensus price target of $15.40, signalling upside risk potential of 16.4%. On the other hand UnitedHealth Group, Inc. has an analysts' consensus of $364.63 which suggests that it could grow by 25.73%. Given that UnitedHealth Group, Inc. has higher upside potential than Oscar Health, Inc., analysts believe UnitedHealth Group, Inc. is more attractive than Oscar Health, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    OSCR
    Oscar Health, Inc.
    0 5 2
    UNH
    UnitedHealth Group, Inc.
    15 6 2
  • Is OSCR or UNH More Risky?

    Oscar Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison UnitedHealth Group, Inc. has a beta of 0.409, suggesting its less volatile than the S&P 500 by 59.094%.

  • Which is a Better Dividend Stock OSCR or UNH?

    Oscar Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group, Inc. offers a yield of 3.01% to investors and pays a quarterly dividend of $2.21 per share. Oscar Health, Inc. pays -- of its earnings as a dividend. UnitedHealth Group, Inc. pays out 65.97% of its earnings as a dividend. UnitedHealth Group, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios OSCR or UNH?

    Oscar Health, Inc. quarterly revenues are $2.8B, which are smaller than UnitedHealth Group, Inc. quarterly revenues of $113.2B. Oscar Health, Inc.'s net income of -$352.4M is lower than UnitedHealth Group, Inc.'s net income of $218M. Notably, Oscar Health, Inc.'s price-to-earnings ratio is 51.21x while UnitedHealth Group, Inc.'s PE ratio is 21.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health, Inc. is 0.31x versus 0.59x for UnitedHealth Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OSCR
    Oscar Health, Inc.
    0.31x 51.21x $2.8B -$352.4M
    UNH
    UnitedHealth Group, Inc.
    0.59x 21.98x $113.2B $218M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 21

RingCentral, Inc. [RNG] is up 34.37% over the past day.

Sell
9
FROG alert for Feb 21

JFrog Ltd. [FROG] is down 24.98% over the past day.

Buy
72
SNSE alert for Feb 21

Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock